Centers For Disease Control And Prevention

This study compares a new 6-week daily rifapentine regimen to the standard 12-16 week treatment for latent tuberculosis infection. About 3,400 people at risk of developing active TB will participate. The goal is to see if the shorter treatment is just as safe and effective at pre…

This study is creating a large national registry of people with ALS in the United States. Researchers will collect information from up to 30,000 participants to better understand how many people have the disease, who is affected, and what environmental or occupational factors mig…